Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to both crafting and globally marketing medical solutions throughout Europe, the United States, and various international territories. A notable product within its development portfolio is MOB-015, a treatment designed for nail fungus, which has successfully concluded its Phase III clinical trials. Established in 2006, this enterprise is headquartered in Bromma, Sweden. It was previously known as Moberg Derma AB (publ) until its rebranding to the current name in May 2013.
Show more...
FAQ
Moberg Pharma AB 今天的股價是多少?▼
MBGPF 目前價格為 $1.10 USD,過去 24 小時上漲了 +4.76%。在圖表上更密切關注 Moberg Pharma AB 股價表現。
Moberg Pharma AB 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,Moberg Pharma AB 的股票以代號 MBGPF 進行交易。
Moberg Pharma AB 的股價在上漲嗎?▼
MBGPF 股票較上週上漲 +0%,本月上漲 +0%,過去一年 Moberg Pharma AB 上漲 +4.76%。
Moberg Pharma AB 的市值是多少?▼
今天 Moberg Pharma AB 的市值為 54.23M
Moberg Pharma AB 下一次財報日期是什麼時候?▼
Moberg Pharma AB 將於 November 12, 2026 公布下一次財報。
Moberg Pharma AB 去年的營收是多少?▼
Moberg Pharma AB 去年的營收為 1.42MUSD。
Moberg Pharma AB 去年的淨利是多少?▼
MBGPF 去年的淨收益為 -2.9MUSD。
Moberg Pharma AB 有多少名員工?▼
截至 September 04, 2026,公司共有 5 名員工。
Moberg Pharma AB 位於哪個產業?▼
Moberg Pharma AB從事於Other產業。
Moberg Pharma AB 何時完成拆股?▼
Moberg Pharma AB 最近沒有進行任何拆股。
Moberg Pharma AB 的總部在哪裡?▼
Moberg Pharma AB 的總部位於 瑞典 的 Bromma。